AdamsCE, RathboneJ, ThornleyB, ClarkeM, BorrillJ, WahlbeckK, AwadAG: Chlorpromazine for schizophrenia: A Cochrane systematic review of 50 years of randomised controlled trials. BMC Med, 3:15, 2005.
2.
BanTA, GuyW, WilsonWH: Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients. Can J Psychiatry, 30:406–408, 1985.
3.
MitkovMV, TrowbridgeRM, LockshinBN, CaplanJP: Dermatologic side effects of psychotropic medications. Psychosomatics, 55:1–20, 2014.
4.
MooreDE: Drug-induced cutaneous photosensitivity: Incidence, mechanism, prevention and management. Drug Saf, 25:345–372, 2002.